On Thursday, Biogen Inc (BIIB) stock saw a decline, ending the day at $164.89 which represents a decrease of $-0.90 or -0.54% from the prior close of $165.79. The stock opened at $165 and touched a ...
Fintel reports that on November 14, 2024, Citigroup initiated coverage of Biogen (NasdaqGS:BIIB) with a Neutral ...
TD Cowen analyst Phil Nadeau maintained a Buy rating on Biogen (BIIB – Research Report) today and set a price target of $275.00. The company’s shares closed yesterday at $164.89. According to TipRanks ...
Currently trading with a volume of 610,232, the BIIB's price is down by -2.38%, now at $160.97. RSI readings suggest the ...
Short BIIB slightly under 174.4, target n/a, stop loss @ 174.9 Check the time stamp on this data. Updated AI-Generated ...
Baird also maintained a Buy rating on the stock with a $300.00 price target ... Begin your TipRanks Premium journey today. Biogen (BIIB) Company Description: Incorporated in 1978, Massachusetts-based ...
Shares of Biogen Inc. BIIB slid 1.48% to $165.79 Wednesday, on what proved to be an all-around favorable trading session for ...
Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback